scispace - formally typeset
M

Michael Letko

Researcher at National Institutes of Health

Publications -  28
Citations -  3602

Michael Letko is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Coronavirus & Medicine. The author has an hindex of 14, co-authored 23 publications receiving 2532 citations. Previous affiliations of Michael Letko include Icahn School of Medicine at Mount Sinai & Skidmore College.

Papers
More filters
Journal ArticleDOI

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.

TL;DR: An approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recently emerged SARS -CoV-2, for receptor usage and their ability to infect cell types from different species is developed.
Journal ArticleDOI

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.

TL;DR: It is shown that intranasal inoculation of SARS-CoV-2 into Syrian hamsters consistently caused moderate broncho-interstitial pneumonia, with high viral lung loads and extensive virus shedding, but animals only displayed transient mild disease.
Posted ContentDOI

Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV

TL;DR: An approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent 2019-nCoV, for receptor usage and their ability to infect cell types from different species is developed.
Journal ArticleDOI

Adaptive Evolution of MERS-CoV to Species Variation in DPP4.

TL;DR: It is demonstrated that MERS-CoV spike can utilize multiple paths to rapidly adapt to novel species variation in DPP4, and enhanced viral entry with suboptimal D PP4 by altering the surface charge of spike.